Does INOTUZUMAB OZOGAMICIN Cause Epistaxis? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Epistaxis have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 0.8% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
19
Reports of Epistaxis with INOTUZUMAB OZOGAMICIN
0.8%
of all INOTUZUMAB OZOGAMICIN reports
6
Deaths
17
Hospitalizations
How Dangerous Is Epistaxis From INOTUZUMAB OZOGAMICIN?
Of the 19 reports, 6 (31.6%) resulted in death, 17 (89.5%) required hospitalization, and 6 (31.6%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for INOTUZUMAB OZOGAMICIN.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Epistaxis Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC